Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 273, Issue 2, Pages 138-155
Publisher
Wiley
Online
2013-04-12
DOI
10.1111/joim.12017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ZEB-1, a Repressor of the Semaphorin 3F Tumor Suppressor Gene in Lung Cancer Cells
- (2015) Jonathan Clarhaut et al. NEOPLASIA
- Merlin/NF2 Regulates Angiogenesis in Schwannomas through a Rac1/Semaphorin 3F-Dependent Mechanism
- (2015) Hon-Kit Wong et al. NEOPLASIA
- Semaphorins in Angiogenesis and Tumor Progression
- (2013) G. Neufeld et al. Cold Spring Harbor Perspectives in Medicine
- Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
- (2013) S. Goel et al. Cold Spring Harbor Perspectives in Medicine
- Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation
- (2012) A Sadanandam et al. BRITISH JOURNAL OF CANCER
- Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity
- (2012) Rodrigo Leite de Oliveira et al. CANCER CELL
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer
- (2012) Luca Tamagnone CANCER CELL
- Neuropilin-1Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
- (2012) Usman Yaqoob et al. CANCER RESEARCH
- Erratum: Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer
- (2012) Atsuko Sakurai et al. CELL RESEARCH
- The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling
- (2012) Chiara Sandri et al. CELL RESEARCH
- Semaphorin3A, Neuropilin-1, and PlexinA1 Are Required for Lymphatic Valve Formation
- (2012) Karine Bouvrée et al. CIRCULATION RESEARCH
- Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform
- (2012) Andrea Casazza et al. EMBO Molecular Medicine
- Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1
- (2012) Matthew W. Parker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
- (2012) Federica Maione et al. JOURNAL OF CLINICAL INVESTIGATION
- Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages
- (2012) C. Meda et al. JOURNAL OF IMMUNOLOGY
- The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities
- (2012) Michele De Palma et al. Molecular Oncology
- Osteoprotection by semaphorin 3A
- (2012) Mikihito Hayashi et al. NATURE
- Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex
- (2012) Froylan Calderon de Anda et al. NATURE NEUROSCIENCE
- Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
- (2012) Annamaria Rapisarda et al. Nature Reviews Clinical Oncology
- Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model
- (2012) Goutam Chakraborty et al. PLoS One
- Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948)
- (2012) Chandrajit P. Raut et al. PLoS One
- TGF- blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
- (2012) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Semaphorin Signaling Meets Rap
- (2012) J. L. Bos et al. Science Signaling
- Plexins Are GTPase-Activating Proteins for Rap and Are Activated by Induced Dimerization
- (2012) Y. Wang et al. Science Signaling
- Diverse roles for semaphorin−plexin signaling in the immune system
- (2012) Hyota Takamatsu et al. TRENDS IN IMMUNOLOGY
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- SEMA3A, a Gene Involved in Axonal Pathfinding, Is Mutated in Patients with Kallmann Syndrome
- (2012) Naresh Kumar Hanchate et al. PLoS Genetics
- Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models
- (2011) Andrea Casazza et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling
- (2011) B. Kigel et al. BLOOD
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
- (2011) Paolo Cirri et al. CANCER AND METASTASIS REVIEWS
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- Polarization of Tumor-Associated Macrophages: A Novel Strategy for Vascular Normalization and Antitumor Immunity
- (2011) Yuhui Huang et al. CANCER CELL
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer
- (2011) Atsuko Sakurai et al. CELL RESEARCH
- PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer
- (2011) J. Liu et al. CLINICAL CANCER RESEARCH
- Cancer-promoting tumor-associated macrophages: New vistas and open questions
- (2011) Alberto Mantovani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nervous vascular parallels: axon guidance and beyond
- (2011) Marco Arese et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
- (2011) Mario Leonardo Squadrito et al. MOLECULAR ASPECTS OF MEDICINE
- Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
- (2011) Sònia Tugues et al. MOLECULAR ASPECTS OF MEDICINE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?
- (2011) Katrien De Bock et al. Nature Reviews Clinical Oncology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Furin Processing of Semaphorin 3F Determines Its Anti-Angiogenic Activity by Regulating Direct Binding and Competition for Neuropilin
- (2010) Matthew W. Parker et al. BIOCHEMISTRY
- Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching
- (2010) G. A. Strasser et al. BLOOD
- Metronomic gemcitabine suppresses tumour growth, improves perfusion and reduces hypoxia in human pancreatic ductal adenocarcinoma
- (2010) K K Y Cham et al. BRITISH JOURNAL OF CANCER
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
- (2010) Neta Erez et al. CANCER CELL
- Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
- (2010) Hon Kit Wong et al. CANCER RESEARCH
- Id2 Promotes Tumor Cell Migration and Invasion through Transcriptional Repression of Semaphorin 3F
- (2010) Silvia Coma et al. CANCER RESEARCH
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Hypoxia, angiogenesis and cancer therapy: To breathe or not to breathe?
- (2010) Paolo Michieli CELL CYCLE
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
- (2010) Amir Abdollahi et al. DRUG RESISTANCE UPDATES
- Evolutionary origins of oxygen sensing in animals
- (2010) Kalle T Rytkönen et al. EMBO REPORTS
- Autocrine Semaphorin3A stimulates eukaryotic initiation factor 4E-dependent RhoA translation in breast tumor cells
- (2010) Hongjie Pan et al. EXPERIMENTAL CELL RESEARCH
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
- (2010) V. Gocheva et al. GENES & DEVELOPMENT
- High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis
- (2010) Anguraj Sadanandam et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation
- (2010) Mackenzie C. McGee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neuropilin-1 Mediates Divergent R-Smad Signaling and the Myofibroblast Phenotype
- (2010) Ying Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-angiogenic therapy: Adapting strategies to overcome resistant tumors
- (2010) Dianne C. Mitchell et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
- (2010) Andrea Casazza et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- An Intact Canonical NF- B Pathway Is Required for Inflammatory Gene Expression in Response to Hypoxia
- (2010) S. F. Fitzpatrick et al. JOURNAL OF IMMUNOLOGY
- A Forward Genetic Screen in Mice Identifies Sema3AK108N, which Binds to Neuropilin-1 but Cannot Signal
- (2010) J. Merte et al. JOURNAL OF NEUROSCIENCE
- Semaphorin 3E Initiates Antiangiogenic Signaling through Plexin D1 by Regulating Arf6 and R-Ras
- (2010) A. Sakurai et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanism of Hypoxia-Induced NF- B
- (2010) C. Culver et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of Motility in Metastasizing Cells
- (2010) Mahmut Yilmaz et al. MOLECULAR CANCER RESEARCH
- Structural basis for semaphorin signalling through the plexin receptor
- (2010) Terukazu Nogi et al. NATURE
- The final steps of integrin activation: the end game
- (2010) Sanford J. Shattil et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- VEGFR2 (KDR/Flk1) Signaling Mediates Axon Growth in Response to Semaphorin 3E in the Developing Brain
- (2010) Anaïs Bellon et al. NEURON
- Mechanisms and Molecules of Neuronal Wiring: A Primer
- (2010) A. L. Kolodkin et al. Cold Spring Harbor Perspectives in Biology
- Semaphorins and tumor angiogenesis
- (2009) Guido Serini et al. ANGIOGENESIS
- Vascular Endothelial Growth Factor
- (2009) Napoleone Ferrara ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships
- (2009) F. Pucci et al. BLOOD
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
- (2009) N. Qayum et al. CANCER RESEARCH
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Inhibition of Semaphorin As a Novel Strategy for Therapeutic Angiogenesis
- (2009) Junji Moriya et al. CIRCULATION RESEARCH
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- Semaphorin signalling
- (2009) Rachel E. Jackson et al. CURRENT BIOLOGY
- Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentation
- (2009) J. Roffers-Agarwal et al. DEVELOPMENT
- Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia
- (2009) Q. Schwarz et al. DEVELOPMENT
- Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development
- (2009) K. J. Reidy et al. DEVELOPMENT
- The Role of Hypoxia in Development of the Mammalian Embryo
- (2009) Sally L. Dunwoodie DEVELOPMENTAL CELL
- Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
- (2009) Annamaria Rapisarda et al. DRUG RESISTANCE UPDATES
- Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages
- (2009) Jong-Dae Ji et al. HUMAN IMMUNOLOGY
- Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis
- (2009) Maria Galluzzo et al. JOURNAL OF CLINICAL INVESTIGATION
- Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis
- (2009) Anguraj Sadanandam et al. MICROVASCULAR RESEARCH
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
- (2009) Hellmut G. Augustin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Role and Therapeutic Potential of VEGF in the Nervous System
- (2009) Carmen Ruiz de Almodovar et al. PHYSIOLOGICAL REVIEWS
- Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy
- (2009) George J. Cerniglia et al. PLoS One
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
- (2009) Debbie Liao et al. PLoS One
- Semaphorin 3E Expression Correlates Inversely with Plexin D1 During Tumor Progression
- (2008) Ilse Roodink et al. AMERICAN JOURNAL OF PATHOLOGY
- Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
- (2008) L. M. Acevedo et al. BLOOD
- Semaphorins and their receptors in lung cancer
- (2008) Vincent A. Potiron et al. CANCER LETTERS
- Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases
- (2008) A. Varshavsky et al. CANCER RESEARCH
- Impact of Angiogenesis Inhibition by Sunitinib on Tumor Distribution of Temozolomide
- (2008) Q. Zhou et al. CLINICAL CANCER RESEARCH
- Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis
- (2008) Guido Serini et al. CURRENT OPINION IN HEMATOLOGY
- Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
- (2008) Michèle Sabbah et al. DRUG RESISTANCE UPDATES
- NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases
- (2008) Fazlul H. Sarkar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- NF-κB and epithelial to mesenchymal transition of cancer
- (2008) Chengyin Min et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment
- (2008) Charlotte Rolny et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages
- (2008) Jose Rafael Sierra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vascular normalization in Rgs5-deficient tumours promotes immune destruction
- (2008) Juliana Hamzah et al. NATURE
- Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
- (2008) Christian Stockmann et al. NATURE
- Perivascular nitric oxide gradients normalize tumor vasculature
- (2008) Satoshi Kashiwagi et al. NATURE MEDICINE
- High-grade glioma before and after treatment with radiation and Avastin: Initial observations
- (2008) Ingeborg Fischer et al. NEURO-ONCOLOGY
- Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
- (2008) Qingyu Zhou et al. NEURO-ONCOLOGY
- Semaphorin signaling: progress made and promises ahead
- (2008) Yeping Zhou et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started